We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Phosphorylation of Glutamate Receptors Critical to Memory Storage

By Biotechdaily staff writers
Posted on 28 Mar 2003
Researchers have genetically engineered a line of mice that are unable to phosphorylate receptors for glutamate molecules in the brain, which resulted in animals with defective mechanisms for storing spatial memories. More...
Their work was reported in the March 7, 2003, issue of Cell.

Mice unable to phosphorylate the GluR1 subunit of the glutamate receptor learned to find a hidden platform in a pool of water as well as normal mice, but could not remember its position eight hours later. In contrast, normal mice remembered what they had learned even after 24 hours.

"Since 1986, phosphorylation has been recognized as a key to modulating receptor responses to neurotransmitters like glutamate, but this is the first demonstration that phosphorylation of a particular target protein mediates the processes we believe are behind learning and memory,” explained senior author Dr. Richard Huganir, professor of neuroscience in the Johns Hopkins School of Medicine's Institute for Basic Biomedical Sciences (Baltimore, MD, USA; www.jhu.edu). "This new work shows that phosphorylation of this target protein does indeed affect an animal's ability to remember.”

"We have established that the two phosphorylation sites on GluR1 are crucial for retention of spatial learning, but it is likely that other sites in other subunits of this glutamate receptor will also play a role,” said Dr. Huganir.



Related Links:
Johns Hopkins University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
POC Immunoassay Analyzer
Procise DX
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.